XM does not provide services to residents of the United States of America.

Boeing's cash flow goal to be delayed, says Wells Fargo as it downgrades stock



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Boeing's cash flow goal to be delayed, says Wells Fargo as it downgrades stock</title></head><body>

Sept 3 (Reuters) -Boeing's BA.N annual free cash flow target of $10 billion may be delayed by about two years to 2027-28and it would have to raise $30 billion before developing a new aircraft, Wells Fargo said and downgraded the stock.

Shares of the Dow component fell more than 7% on Tuesday after lead analyst Matthew Akers pushed Boeing to "underweight" and trimmed the target price to $119, a 32% downside to the last closing price.

"Boeing carries about $45 billion net debt and (it) must address this before it kicks off the next aircraft development cycle," Akers said, adding that cutting the debt would consume its cash flow through 2030.

The planemaker is working to recover from a crisis sparked by a mid-air accident in January that led to regulatory curbs on its 737 MAX production, which has pressured its free cash flow.

"Given a likely new aircraft launch in the next few years, Boeing will need to shore up the balance sheet sooner," said Akers, who is rated three out of five stars for estimate accuracy on LSEG Workspace.

"We estimate a roughly $30 billion equity raise to get back to zero net debt by 2027."

Boeing, whose shares have lost nearly 33.5% of their value this year, was not immediately available for a comment.

The company had in 2022 outlined annual cash flow target of $10 billion by 2025 or 2026. Its CFO had earlier this year warned that the company may need more time to hit that goal.

Boeing's FCF per share could grow to about $20 later this decade if it were to delay new planes for "several more years" and instead just pay down debt, Akers said, but that would risk ceding market share to rival Airbus SE AIR.PA in the long run.



Reporting by Pratyush Thakur in Bengaluru; Editing by Shreya Biswas

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.